Phase II Study Folfirinox followed my Individualized Radiation Therapy with Borderline Resectable Pancreatic Cancer
Theodore S. Hong, MD of Massachusetts General Hospital outlines a Phase II Study of Folfirinox followed my Individualized Radiation Therapy with Borderline Resectable Pancreatic Cancer at ASCO GI 2017...
Author: ASCOGI2017
Added: 01/26/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Hospitals | Pancreas | Pancreatic Cancer | Radiation Therapy | Study